History
Sinclair Pharmaceuticals Limited was originally founded in 1971 by Andrew Sinclair to focus on the sale and marketing of pharmaceutical products in the UK.
From then, it has constantly consolidated its presence & turnover in the five leading European markets & developed its global reach through solid partnerships.
Sinclair Pharma keeps growing through company & product acquisitions, full-exploitation of in-house technologies & in/out-licensing partnerships.
| 1971 |
- Creation of Sinclair Pharma
- Sale and marketing of pharmaceutical products in the UK
|
| 2000 |
- Sinclair Pharma acquired by new management team
- Acquisition of Salix Pharma (Sweden) bringing SST for xerostomia
|
| 2001 |
- Acquisition of ProPharma (Italy), bringing dermatology range including Atopiclair.
|
| 2002 |
- Acquisition of Biosurface (Sweden), bringing Decapinol for gingivitis.
|
| 2003 |
|
| 2005 |
- Acquisition of Euroderm (Italy).
|
| 2006 |
- Acquisition of CS Dermatologie, bringing dermatology range including Fazol, Tridésonit
|
| 2009 |
- Company refinanced. New management team. Chris Spooner appointed as CEO
- Acquisition of Flammazine & Flammacerium
- Creation of Sinclair GmbH (Germany)
- Acquisition of Sinclair Pharmaceutical España (Spain)
|